Last updated on November 2017

A Phase 2b, Randomized, Doubl-blind, Placebo-controlled, Parallel-group, Dose-ranging-finding Trial of XXXXX Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors


Brief description of study

A Phase 2b, Randomized, Doubl-blind, Placebo-controlled, Parallel-group, Dose-ranging-finding Trial of XXXXX Administered Orally for 8 Weeks to Patients with Symptomatic Gastroesophageal Reflux Disease Not Completely Responsive to Proton Pump Inhibitors

Detailed Study Description

A study to enroll patients who have GERD and continue to experience GERD symptoms while receiving once daily proton pump inhibitors.

Clinical Study Identifier: TX6329

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Jennifer Wu

IMA Research
Kew Gardens, NY USA
  Connect »